The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Stepanov I.A.

Irkutsk State Medical University

beloborodov V.A.

Irkutsk State Medical University

Shameeva M.A.

Irkutsk State Medical University

Borisov E.B.

Buryat Republican Clinical Oncology Dispensary

Shagdurova I.A.

Buryat Republican Clinical Oncology Dispensary

Risk factors for the development and progression of vertebral compression fractures in patients with multiple myeloma

Authors:

Stepanov I.A., beloborodov V.A., Shameeva M.A., Borisov E.B., Shagdurova I.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2021;10(2): 15‑21

DOI: 10.17116/onkolog20211002115

Views: 2580

Downloaded: 58

Download PDF (RU)
Contact the author
Table of contents

RISK FACTORS FOR THE DEVELOPMENT AND PROGRESSION OF VERTEBRAL COMPRESSION FRACTURES IN PATIENTS WITH MULTIPLE MYELOMA
RISK FACTORS FOR THE DEVELOPMENT AND PROGRESSION OF VERTEBRAL COMPRESSION FRACTURES IN PATIENTS WITH MULTIPLE MYELOMA

To cite this article:

Stepanov IA, beloborodov VA, Shameeva MA, Borisov EB, Shagdurova IA. Risk factors for the development and progression of vertebral compression fractures in patients with multiple myeloma. P.A. Herzen Journal of Oncology. 2021;10(2):15‑21. (In Russ.)
https://doi.org/10.17116/onkolog20211002115

Подписка 2025-2 (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Close metadata

OBJECTIVE

To study the risk factors for the development and progression of vertebral compression fractures in patients with multiple myeloma (MM).

MATERIAL AND METHODS

A multicenter retrospective observational cohort study was conducted. The study included respondents’ medical records, in which the diagnosis of MM was confirmed by clinical, instrumental, and laboratory examinations. The respondents’ clinical and instrumental parameters were studied.

RESULTS

Taking into account the eligibility criteria, 175 patients with MM were included in the study and examined. The mean follow-up period for the respondents was 29±19 months. Among the 1964 vertebrae studied, there were 219 (12.9%) vertebral compression fractures. The latter were morphologically characterized as follows: the fractures were biconcave in 95 (43.3%) cases, wedge-shaped in 113 (51.5%), and comminuted in 11 (5%). The results of a multivariate analysis demonstrated a statistically significant effect of Stage II—III of the disease (odds ratio (OR) = 3.18 and 3.77, respectively), low back pain syndrome (OR=4.24), fracture morphology (biconcave, wedge-shaped, and comminuted fractures) (OR=5.44, 3.81, and 17.8), Hounsfield density unit values (OR=0.96), the localizations of osteodestruction foci (OR=2.01, 3.17, and 3.22), and existing spinal deformities (OR=1.97 and 1.15) on the risk of the development and progression of vertebral compression fractures in patients with MM.

CONCLUSION

The risk for the development and progression of vertebral compression fractures in patients with MM is significantly influenced by Stages II—III of the disease, back pain syndrome, fracture morphology, Hounsfield density unit values, the localization of osteodestruction foci, and existing spinal deformities.

Keywords:

multiple myeloma
vertebral compression fractures
risk factors
clinical parameters
instrumental parameters

Authors:

Stepanov I.A.

Irkutsk State Medical University

beloborodov V.A.

Irkutsk State Medical University

Shameeva M.A.

Irkutsk State Medical University

Borisov E.B.

Buryat Republican Clinical Oncology Dispensary

Shagdurova I.A.

Buryat Republican Clinical Oncology Dispensary

Received:

21.11.2020

Accepted:

10.12.2020

List of references:

  1. Vorob’ev AI, Abramov MG, Brilliant MG, eds. Guide to hematology. M.: Meditsina; 2002. (In Russ.).
  2. Rukavitsyn OA, ed. Hematology. National guidelines. M.: GEOTAR-Media; 2017. (In Russ.).
  3. Pop VP, Rukavitsyn OA. Multiple myeloma and related diseases. 3rd ed. M.: GEOTAR-Media; 2016. (In Russ.).
  4. Kazandjian D. Multiple myeloma epidemiology and survival: A unique malignancy. Semin Oncol. 2016;43(6):676-681.  https://doi.org/10.1053/j.seminoncol.2016.11.004
  5. Brigle K, Rogers B. Pathobiology and diagnosis of multiple myeloma. Semin Oncol Nurs. 2017;33(3):225-236.  https://doi.org/10.1016/j.soncn.2017.05.012
  6. Kehrer M, Koob S, Strauss A, Wirtz DC, Schmolders J. Multiple myeloma — current status in diagnostic testing and therapy. Z Orthop Unfall. 2017;155(5):575-586.  https://doi.org/10.1055/s-0043-110224
  7. Kyriakou C, Molloy S, Vrionis F, Alberico R, Bastian L, Zonder J, Giralt S, Raje N, Kyle R, Roodman D, Dimopoulos M, Rajkumar S, Durie B, Terpos E. The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG). Blood Cancer J. 2019;9(3):27.  https://doi.org/10.1038/s41408-019-0187-7
  8. Marino S, Roodman GD. Multiple myeloma and bone: the fatal interaction. Cold Spring Harb Perspect Med. 2018;8(8):a031286. https://doi.org/10.1101/cshperspect.a031286
  9. Smith N, Kimberger K, Parrish C, Currie S, Butterworth S, Alty J. Multiple myeloma with multiple neurological presentations. Pract Neurol. 2019;19(6):511-517.  https://doi.org/10.1136/practneurol-2019-002205
  10. Kehrer M, Koob S, Kehrer A, Wirtz DC, Schmolders J. Multiple myeloma — current standards in surgical treatment. Z Orthop Unfall. 2019;157(2):164-172.  https://doi.org/10.1055/a-0639-5742
  11. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495-1499. https://doi.org/10.1016/j.ijsu.2014.07.013
  12. Spasov E, Goranova V. Prognostic assessment of the Durie and Salmon staging system in patients with multiple myeloma. Folia Med (Plovdiv). 1998;40(3B suppl 3):121-123. 
  13. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J. International staging system for multiple myeloma. J Clin Oncol. 2005;23(15):3412-3420. https://doi.org/10.1200/JCO.2005.04.242
  14. Lenchik L, Rogers LF, Delmas PD, Genant HK. Diagnosis of osteoporotic vertebral fractures: importance of recognition and description by radiologists. AJR Am J Roentgenol. 2004;183(4):949-958.  https://doi.org/10.2214/ajr.183.4.1830949
  15. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. https://doi.org/10.1001/jama.2013.281053
  16. Rajkumar SV. Multiple myeloma: Every year a new standard? Hematol Oncol. 2019;37(suppl 1):62-65.  https://doi.org/10.1002/hon.2586
  17. Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer. 2007;7(8):585-598.  https://doi.org/10.1038/nrc2189
  18. Mehta A. Multiple myeloma. Hematology. 2015;20(1):58-59.  https://doi.org/10.1179/1024533214Z.000000000333
  19. Lasocki A, Gaillard F, Harrison SJ. Multiple myeloma of the spine. Neuroradiol J. 2017;30(3):259-268.  https://doi.org/10.1177/1971400917699426
  20. Xiao R, Miller JA, Margetis K, Lubelski D, Lieberman IH, Benzel EC, Mroz TE. Predicting the progression of vertebral fractures in patients with multiple myeloma. Spine J. 2016;16(4):510-515.  https://doi.org/10.1016/j.spinee.2015.12.014
  21. Miller JA, Bowen A, Morisada MV, Margetis K, Lubelski D, Lieberman IH, Benzel EC, Mroz TE. Radiologic and clinical characteristics of vertebral fractures in multiple myeloma. Spine J. 2015;15(10):2149-2156. https://doi.org/10.1016/j.spinee.2015.05.026
  22. Chen YL, Liu YC, Wu CH, Yeh CM, Chiu HI, Lee GY, Lee YT, Hsu P, Lin TW, Gau JP, Hsiao LT, Chiou TJ, Liu JH, Liu CJ. Role of BMI and age in predicting pathologic vertebral fractures in newly diagnosed multiple myeloma patients: A retrospective cohort study. Hematol Oncol. 2018;36(2):407-415.  https://doi.org/10.1002/hon.2486
  23. Zijlstra H, Wolterbeek N, Drost RW, Koene HR, van der Woude HJ, Terpstra WE, Delawi D, Kempen DHR. Identifying predictive factors for vertebral collapse fractures in multiple myeloma patients. Spine J. 2020;20(11):1832-1839. https://doi.org/10.1016/j.spinee.2020.07.004
  24. Armas LA, Recker RR. Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin North Am. 2012;41(3):475-486.  https://doi.org/10.1016/j.ecl.2012.04.006
  25. Sapir-Koren R, Livshits G. Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link. Bone. 2017;103:102-115.  https://doi.org/10.1016/j.bone.2017.06.020
  26. Nguyen HS, Soliman HM, Patel M, Li L, Kurpad S, Maiman D. CT hounsfield units as a predictor for the worsening of traumatic vertebral compression fractures. World Neurosurg. 2016;93:50-54.  https://doi.org/10.1016/j.wneu.2016.05.069
  27. O’Rourke RW. Adipose tissue and the physiologic underpinnings of metabolic disease. Surg Obes Relat Dis. 2018;14(11):1755-1763. https://doi.org/10.1016/j.soard.2018.07.032
  28. Chen D, Xie R, Shu B, Landay AL, Wei C, Reiser J, Spagnoli A, Torquati A, Forsyth CB, Keshavarzian A, Sumner DR. Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging. Ann N Y Acad Sci. 2019;1442(1):48-60.  https://doi.org/10.1111/nyas.13945
  29. Głogowska-Szeląg J, Szeląg M, Stolecki M, Kudła M. Obesity and osteoporosis-connections between adipose tissue and bone. Wiad Lek. 2019;72(9, cz 2):1834-1838.
  30. Jang KU, Lee JS, Jang HS. Incidental diagnosis of multiple myeloma during the treatment of low back pain: A case report. Korean J Anesthesiol. 2009;56(1):120-123.  https://doi.org/10.4097/kjae.2009.56.1.120
  31. Tosi P. Diagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvement. Scientifica (Cairo). 2013;2013:104546. https://doi.org/10.1155/2013/104546
  32. Anitha D, Baum T, Kirschke JS, Subburaj K. Risk of vertebral compression fractures in multiple myeloma patients: A finite-element study. Medicine (Baltimore). 2017;96(2):e5825. https://doi.org/10.1097/MD.0000000000005825

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.